In the last decade, since the first report of induced pluripotent stem cells, the stem cell field has made remarkable progress in the differentiation to specialized cell-types of various tissues and organs, including the heart. Cardiac lineage-and tissue-specific human pluripotent stem cell (hPSC) reporter lines have been valuable for the identification, selection, and expansion of cardiac progenitor cells and their derivatives, and for our current understanding of the underlying molecular mechanisms. In order to further advance the use of hPSCs in the fields of regenerative medicine, disease modeling, and preclinical drug development in cardiovascular research, it is crucial to identify functionally distinct cardiac subtypes and to study their biological signaling events and functional aspects in healthy and diseased conditions. In this review, we discuss the various strategies that have been followed to generate and study fluorescent reporter lines in hPSCs and provide insights how these reporter lines contribute to a better understanding and improvement of cell-based therapies and preclinical drug and toxicity screenings in the cardiac field. STEM CELLS 2015; 00:000-000
INTRODUCTION
Human pluripotent stem cells (hPSCs), that is, embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), can be maintained in culture indefinitely and since they have the potential to differentiate into any cell type of the human body, these cells offer an unlimited source of differentiated cell types, including cardiomyocytes (CMs). The promise of hPSCderived CMs for treatment of heart disease has grown rapidly since the ability to reprogram somatic cells into iPSCs, discovered for the first time by Yamanaka et al. in 2006 [1] . IPSCs are very similar to ESCs, but are of a less ethical concern, as they do not require donated embryos for derivation. Furthermore, they can be generated from patients with genetic disease to create in vitro human disease models.
In recent years, the differentiation efficiency from hPSCs to cardiac cells has increased considerately, yielding 60%-90% CM cultures [2] . Efficient directed differentiation of CMs from hPSCs is of high interest for multiple fields of research, including cardiogenesis, in vitro disease modeling, drug discovery, safety pharmacology, and regenerative medicine. Fluorescent reporter lines offer the opportunity to monitor cell subtype specification and to investigate underlying molecular mechanisms during differentiation of hPSCs toward cardiac cells, and to track cells in cell-based therapies. In order to generate fluorescent reporter lines, hPSCs need to be genetically modified, which can be performed through different approaches. A variety of fluorescent proteins that cover a broad range of the wavelength spectrum, including eGFP, mCherry, and mVenus, enable imaging and tracking of specific cell populations and mapping their cell fate. Here, we will summarize the different fluorescent reporter lines that have been described so far, how these were generated, and how they have contributed to our current knowledge on cardiac progenitors segregation, proliferation, and subtype specification. Furthermore, we describe their importance for applications in regenerative medicine (e.g., replacing damaged or nonviable heart tissue) and further advancing in vitro systems for disease modeling and drug discovery and safety testing ( Fig. 1 ).
METHODS FOR GENERATING PSC REPORTER LINES
For selection and purification of specific cell types, nongenetic approaches such as metabolic selection or sorting using cell type-specific antibodies are preferred. However, these approaches are not always available or fail to yield sufficient purity, and therefore, the use of cell-type-specific fluorescent reporter lines offers an excellent alternative. Generation of these reporter lines require genetic engineering in hPSCs, for which several successful approaches have been described. Each genetic engineering approach knows its own advantages and disadvantages, which we will discuss here briefly (Table 1) . More specific details can be found elsewhere [3] [4] [5] .
Promoter-Driven Reporter Lines
Introducing exogenous regulatory fragments that are coupled to a fluorescent reporter gene can generate cell-specific promoter reporter lines. These elements can be introduced randomly into the genome through viral-mediated transduction [6] , electroporation, nucleofection, or chemical-based transfection. However, important shortcomings exist in using these methods. First, integration events are random and there is no control over copy number, site of integration, and gene expression level. Moreover, chromatin dynamics and epigenetic regulators may change upon lineage differentiation, resulting in the chance of transgene silencing disabling gene reporter expression [7] [8] [9] . Second, endogenous regulatory elements may interfere with the incorporated promoter/enhancer elements, so that the fluorescent reporter may not faithfully recapitulate endogenous activation of the target gene during differentiation. The use of strong insulator elements flanking the enhancer and its reporter gene could be a way to overcome transgene silencing [9, 10] . Moreover, endogenous elements themselves could be influenced by the integration of new regulatory elements, which may affect the differentiation process, cellular behavior, and function. Several loci have been described to be ubiquitously expressed in human ESCs (hESCs) and progeny, including sequences highly homologous to the mouse Rosa26 locus and the adeno-associated virus integration site 1 (AAVS1) locus, which could be targeted through homologous recombination [11] [12] [13] . However, it should be noted that transgene silencing can be lineage-specific and the effect of gene expression following gene insertion in these loci has not been described for all mature cell-types. Third, these strategies are always based on restricted regulatory elements, often based on conserved elements between species. However, gene regulation is complex and can be regulated through combinatorial distal and proximal elements that control the precise expression pattern of a gene during development [14] , and therefore detailed knowledge of specific regulatory elements and their effect on gene regulation is required. The best way to overcome these limitations is the development of a knock-in PSC line.
Targeted Genome Editing
With targeted genome editing, a reporter gene is inserted into a specific site at the gene of interest through homologous recombination [15] . In recent studies using cardiac reporter lines in hESCs, sequences following the translation start codon of the [16, 17] . Sequential excision of the selection cassette is recommended in order to prevent interfering regulatory events at the targeted site [18] . One major disadvantages of this strategy is the generation of haploinsufficient hPSC lines, since in one allele the targeted gene of interest has been replaced with a fluorescent encoding protein. Therefore, it is important to have additional information on whether heterozygote expression of the target gene may affect differentiation and cellular functions. For example, studies in knockout mice or comparable strategies in other species may provide this information. Alternatively, an internal ribosomal entry site (IRES) or viral 2A peptide may be incorporated in the targeting construct in order to allow expression and translation of both the endogenous as well as the reporter genes [19] . However, in case of the use of IRES, it has been shown by many researchers that transcription of the second gene is less efficient than the first, which also depends on the strength of the endogenous promoter [20, 21] . Viral 2A could be a superior alternative to the widely used IRES. Using a short sequence, multiple proteins can be coexpressed from a single mRNA. However, the disadvantage is that due to ribosomal cleavage of the 2A sequence, several amino acids are added to the C terminus of the endogenous protein, and one amino acid is added to the N terminus of the reporter protein, which may have an effect on the function or turnover of proteins [19, 22] .
The Promise of Engineered Nucleases
Other site-specific genetic engineering methods that have raised interest in recent years are engineered nucleases, including zinc-finger nucleases (ZFNs) [23, 24] , transcription activator-like effector nucleases (TALENs), or the most recently described clustered regularly interspaced short palindromic repeats (CRISPR) technology [4] . Important considerations to take into account when choosing a specific technology, include the size of the insertion sequence, the risk for offtarget modifications [25] , and the prospected efficiency of the targeting. CRISPR technology has shown high efficiency (up to 51%-79% in hPSCs) [26] and reliability (low off target effects) in site-specific amino acid replacement, and is considered a promising technique for disease modeling or for genetic repair. Moreover, compared to ZFNs or TALENs, it only requires the generation of a single guidance RNA (sgRNA) molecule, CAS nuclease mRNA, and a donor vector in case of an insertion, which makes it much less labor-intensive [5] . Jaenisch and coworkers have shown that the use of CRISPR/ Cas9 can be successfully used for the efficient generation of fluorescent gene reporters in mice [27] . Here, Cas9 mRNA, sgRNA, and a donor vector containing a 3 kb transgene cassette were injected into zygotes. From the blastocyst stagederived mESCs, 33% were correctly targeted. However, limitations still exist and may be different in hPSCs; here, the insertion of large DNA constructs into the genome has not been described yet. For CRISPR/CAS9 technology, limitations include the variance in targeting efficiency, which depends on the size of the epitope or fluorescent tag, the amount of targeting vector to be injected, cell type, cell cycle phase [28] , and the target locus, and will require model-specific optimization. More specific details are reviewed elsewhere [4, 29] .
In summary, several aspects are important to take into account for generating fluorescent reporter lines, such as the amount of time and labor it takes to generate a line, the efficiency of targeting, the choice for a replacement or a fusion strategy, random gene insertions from lentiviral particles, the risk of silencing, the risk for off-target effects from nucleases, and the size of the DNA construct (a fluorescent protein and/ or selection cassette). An overview of the genetic engineering methods that have been used to introduce reporter constructs in PSCs for cardiac development/differentiation and transplantation studies can be found in Table 1 . So far, most cardiac fluorescent reporter PSCs have been generated through the use of lentiviral or homologous recombination approach, although it is expected that future studies will increasingly report generation of fluorescent reporter lines through the use of engineered nucleases [4, 28] .
Fluorescent Reporters to Study Segregation of Early Cardiac Progenitors
In Vivo Cardiac Development. Since differentiation of hPSCs to the cardiac lineage recapitulate the early steps of in vivo heart development [30] , a thorough understanding of the molecular cues and signaling pathways of this developmental process is essential. The earliest precursors for heart-forming cells are derived upon ingression of epiblast cells through the vertebrate primitive streak. During this event, called gastrulation, cells undergo epithelial-to-mesenchymal-transition and form mesendoderm. They are marked by activation of transcription factors, including T-box transcription factor brachyury T (BryT) and homeodomain transcription factor MIXL1 [31] [32] [33] . Another transcription factor, Eomesodermin, is restricted to the anterior region of the primitive streak [34] , and together with BryT they act upstream of bHLH transcription factor MESP1. In combination with low Nodal signaling, this results in the transition from a mesendodermal stage to a more defined precardiac subpopulation, marked by MESP1 [35] [36] [37] . Almost all cells of the final developing heart, but also hematopoietic and skeletal myogenic lineages, are derived from MESP1-expressing early progenitors [38, 39] . Recently, a more restricted cardiac progenitor cell population, derived from Mesp1, and marked by Smarcd3 was described [40] . However, information on the segregation and existence of intermediate cardiac progenitors is sparse. Based on recent clonal analysis studies in mice, early cardiovascular lineage specification is described to occur prior to, or during, Mesp1 expression [40, 41] , which distinguishes the so-called first heart field (FHF, which forms the initial heart tube, and later the left ventricle [LV] and some of the right ventricle and atria) from the second heart field (SHF, marked by ISL1 expression, which forms the right ventricle [RV], atria, and outflow tract [42] ). FHF progenitors are located within the socalled cardiac crescent, and following migration and fusion at the midline, a primitive heart tube is formed. SHF cells are located medially and posteriorly to the cardiac crescent and contribute to the formation of the heart at a later stage. In the developing human heart, ISL1-expressing progenitors are described to differentiate to different downstream multipotent heart progenitors that contribute to SHF-derivatives [43, 44] . In contrast, the highly conserved cardiac transcription factor 4 Fluorescent reporters in stem-cell derived cardiomyocytes.
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STEM CELLS NKX2-5 is first expressed in the cardiac crescent, but later as well in SHF-derived cardiac cells. Expression of NKX2-5 is maintained throughout the developing and adult heart [45] .
In Vitro Cardiac Reporter Lines. A genetically modified mouse ES cell line, in which Mesp1 regulatory regions were coupled to a green fluorescent protein (GFP) reporter, showed the ability to isolate and study early Mesp1-GFP cells upon cardiac differentiation [46] . They identified the cell surface markers CXCR4, Flk1, and PDGFRa to be specifically expressed in Mesp1-progenitors in mice. Single-cell clone analysis demonstrated the heterogeneous expression of early cardiac genes, including Isl1, indicating early segregation of Mesp1 progenitors into different downstream multipotent cardiac progenitors. This was confirmed by an in vivo study in mouse, where they showed early segregation of the FHF and SHF, during MESP1 expression [41] . Recently, we characterized for the first time human precardiac MESP1-progenitors differentiating to the cardiac lineage [16] . We performed targeting of the genomic locus of MESP1 through homologous recombination by replacing one allele with a DNA sequence encoding for the fluorescent protein mCherry. Microarray analysis of MESP1-mCherry positive cells largely revealed similar transcriptional characteristics to those in mice. However, a clear difference between mouse and human cardiac cell differentiations is that human MESP1 progenitors appear to have a more demarcated mesodermal character, as only a small subset of early cardiac genes is expressed in this population, including GATA4, MYL4, and MYL7. Interestingly, we also identified the absence of surface markers that were previously identified on mouse Mesp1-GFP progenitors [46] . Human MESP1 progenitors do highly express PDGFRa protein, but not CXCR4, and only a low percentage expresses KDR (Vascular endothelial growth factor receptor 2), indicating the presence of a PDGFRa1KDR2 cardiac progenitor population, besides the previously described human KDR1PDGFR 1 cardiac progenitor [47] .
As described above, the LIM (LIN-11, ISL-1 and MEC-3 proteins) homeodomain transcription factor Isl1 is enriched in the secondary heart field [42] . Mouse multipotent Isl1 1 cardiac progenitors contribute to endothelial, endocardial, smooth muscle, the conduction system, right ventricular, and atrial CMs [43, 48] . By generating an in vitro Isl1-Cre Knock-in DsRed reporter line in hESCs for lineage tracing construct it was found that human ISL1 1 progenitors can give rise to CMs (cTnT), endothelial cells (PECAM1), and smooth muscle cells (SM-MHC) [44] . Furthermore, this study, and several others, showed expansion of Isl1 1 progenitors under activation of the Wnt/B-catenin-pathway [44, 49, 50] . More insight in the ability to maintain and expand cardiac progenitors may provide an unlimited source of cells committed to form cardiovascular cells.
As mentioned previously, NKX2-5 is a key cardiac transcription factor and is expressed in heart precursor cells in the FHF, which are committed to the cardiac lineage [51] . Elliott et al. designed a NKX2-5 fluorescent reporter line in hESCs, by targeting a DNA sequence encoding for eGFP into the NKX2-5 genomic locus through homologous recombination [17] . Since NKX2-5 is activated in cardiac progenitors and expression is maintained in functional CMs at later stages, this reporter line is very suitable for studying the effect of small molecules and growth factors during cardiac lineage differentiation from hESCs. Indeed, following this approach, a more efficient, robust, and defined differentiation protocol was developed. In addition, Birket et al. recently showed in a MYC-inducible system expansion of hESC-derived NKX2-5-eGFP 1 progenitors for many passages through IGF-1 and hedgehog signaling, from which different cardiac subpopulations, including nodal-like cells, could be obtained [52] . Furthermore, using antibody arrays and geneexpression arrays, a cell surface protein signal regulatory protein (SIRPA/CD172a) was identified as a marker for early cardiac progenitor cells. Upon further differentiation, coexpression of SIRPA with VCAM1 was identified to specifically enrich for CMs [17, 53] . Interestingly, SIRPA is not expressed in the developing mouse heart, in contrast to the human heart, which highlights the need to define markers in the human system. The previously described MESP1-mCherry targeting was performed in this NKX2-5-eGFP hESC line, yielding a dual cardiac reporter line (Fig. 2) [16] , which facilitates studying molecular pathways that are involved in the early switch from hESCs to precardiac mesoderm, and its subsequent differentiation toward the cardiac lineage and specification into different cardiac subtypes. This could also provide opportunities for monitoring cardiaccommitted progenitors (MESP11) to NKX2-5 1 CMs following transplantation in infarcted hearts (see Fluorescent Reporters to Track Cells After Transplantation section).
Fluorescent Reporters to Study CM Derivation
The major cell types of the heart include ventricular and atrial CMs, cardiac conduction cells, vascular smooth muscle cells, endothelial cells (myocardium and endocardium), and cardiac fibroblasts. Both for cardiac regeneration therapies and biomedical applications it is important to establish defined scalable culture systems or tissue constructs consisting either of pure cardiac cell populations or a well-balanced and controlled mixture of cardiac cells resembling the composition and architecture of the human heart. However, current cardiac differentiation protocols result in a mixture of cardiac and noncardiac cell-types. Approaches to purify cell populations using fluorescent reporter lines under the control of cardiac-and/or subtype-specific promoters have been first performed in mESCs [54] [55] [56] [57] . In hESC, an alpha-MHC or NCX-1 promoter, coupled to either a fluorescent protein (eGFP, mCherry), or the antibiotic resistance gene, puromycin, has been introduced into the genome [6, [58] [59] [60] . In the study of Kita-Matsuo et al., a-MHC positive CMs were selected in the presence of puromycin for 36 hours (day 12 to day 13.5), which yielded 92%-96% pure CMs (based on quantifications of cardiac Troponin I immunostainings) [6] . Differentiation of NCX-1-eGFP hESCs resulted in a maximum of 650% of NCX-1-eGFP 1 CMs, highly enriched for early and late cardiac genes, including NKX2-5, TBX5, cardiac troponin T, MYH6, and MYH7 [59] . However, as alpha-MHC and NCX-1 are both expressed in all types of CMs, this results in a mixture of nodal, atrial-, and ventricular-like CMs. However, Both NCX-1 (Na 1 / Ca 21 exchanger) and alpha-MHC are widely expressed in all subtypes, resulting in a mixture of nodal, atrial-, and ventricular-like CMs [6, 59] . Ventricular CMs. In order to select ventricular CMs, promoter/enhancer elements of ventricular-specific (or -enriched) genes, such as ventricular myosin light chain 2v (MLC2V) or IRX4 could be appropriate candidates for generating subtypespecific reporter lines [61] . MLC2V expression is restricted to the ventricular segment of the developing human heart, followed by expressed in the entire ventricular compartment in the adult heart [62] . It is noteworthy that different cis-acting regulatory elements may be responsible for MLC2V expression in either the LV or RV, indicating differences in the regulation of their derivation and the possibility to identify and purify left (predominantly FHF-derived) or right ventricular (predominantly SHF-derived) CMs [45, 63] . Huber and colleagues generated hESCs stable lines, using lentiviral vectors that expressed fluorescent protein eGFP under the transcriptional control of a highly conserved 250 bp MLC2V promoter element [64] . This enabled a highly enriched population of ventricular-like cells, purified by fluorescence-activated cell sorting [65] . It should be noted that the used promoter is dominantly active in right ventricular CMs [64] . Alternatively, the use of a drug resistance gene under the control of a ventricular-specific promoter may be another strategy. A disadvantage of selecting ventricular CMs through the MLC2V promoter is its low expression level in early stage hPSC-CMs. Substantial MLC2V expression levels are displayed only after long-term cultures for approximately a month, which is correlated to a higher degree of maturation [66] . Interestingly, most CM differentiation protocols that exist show a preferred differentiation to the ventricular lineage. However, it is not known whether these ventricular cells are derived from the same or from different cardiac progenitor cells, and whether this is important for the development of directed differentiation protocols. The use of dual or multireporter hPSC lines may provide better insights in this matter.
Atrial CMs. Factors that determine fate specification of atrial CMs are largely unknown [67] , although several atrial-specific or -enriched genes have been identified previously in different species. For example, myosin light chain 2A (MLC2A) is initially expressed throughout the tubular heart in the mouse embryo, and becomes only confined to the atrial segment during chamber formation [45] . This is in contrast with human cardiac development, where MLC2A transcript was found in both atria and ventricles at even later stages of development [62] , signifying the importance to understand the molecular mechanisms that are involved at the different stages of human cardiac development in order to serve as a blueprint for directed step-wise cardiac differentiation of hPSCs. Recently, the orphan nuclear receptor COUPTFII was identified as an important regulator of atrial development in mice [67] . Upon in vitro cardiac differentiation from hPSCs in the presence of retinoic acid, we recently demonstrated that both COUPTFI and COUPTFII are involved in atrial CM derivation [68] . Moreover, both transcription factors were highly enriched in human atria at RNA and protein levels during cardiac development and both genes may represent interesting candidates for generating atrial-specific reporter hPSC lines. However, expression of COUPTFII can also be found in venous/lymphatic endothelium, vascular smooth muscle cells, the endocardium, and the epicardium [69] .
Nodal-Like CMs. For understanding molecular pathways leading to differentiation of nodal-like hESC-CMs and to allow their isolation, promoter-enhancer elements of several genes involved in the development of nodal tissue have been used so far. Previously, in vivo studies in mice showed selective activation of a chicken GATA6 (cGATA6) proximal promoterenhancer element in the atrioventricular node and the bundle of His of the adult mouse heart [70] . Zhu and colleagues coupled this cGATA6 regulatory element to eGFP in a lentiviral construct and subsequently transduced hESCs prior to differentiation (with a transduction efficiency of only 50%). By adjusting cardiac differentiation via inhibition of Neuregulin-1/ ErbB signaling, an increased proportion of nodal-like CMs was identified [71] . cGATA6-eGFP-positive cells exhibited action potential characteristics of a nodal-phenotype, indicated by the increased expression of HCN4, responsible for the funny current I f , and transcription factor TBX3, important for in vivo specification of nodal tissue. Studies in mouse tested Hcn4 promoter/enhancer elements to investigate the derivation of nodal-like CMs, in vitro [72, 73] . Differentiating Hcn4-promoter-GFP mESCs resulted in only a small percentage of Hcn4-positive cells (61%) exhibited a pacemaker-like action potential after fluorescent-based isolation [72] . Direct reprogramming of HCN4-GFP fibroblasts, using a combination of four transcription factors (Tbx3, Tbx5, Gata6, and Rxra), robustly activated HCN4p-GFP expressing cells, but without displaying electrical activity and no expression of sarcomeric proteins [73] . Alternative approaches for directed differentiation including the use of RNA molecules, such as modified mRNA, miRNAs, or lncRNAs, are currently evaluated. Important to note is that at the cardiac crescent stage, Hcn4 is also expressed in early FHF progenitors and immature CMs [73] [74] [75] [76] , and only becomes confined to components of the conduction system at later stages of development [77] , which is of critical importance to realize when studying the derivation of human conduction cells.
THE PROMISES AND CHALLENGES OF HPSC-DERIVED CMS FOR CELLULAR THERAPY
Initially, researchers focused on the potential of hPSC-derived CMs for cell replacement therapy in experimental models of heart disease, such as myocardial infarction (MI) [78, 79] . In order to restore heart function and maintain long-term beneficial effects, sufficient transplanted cells need to engraft at 6 Fluorescent reporters in stem-cell derived cardiomyocytes.
V C AlphaMed Press 2015 the site of injury, receive blood supply, and need to couple and communicate with cardiac cells of the host myocardium in order to ensure synchronous electrophysiological and contractile function. CMs derived from human iPSCs would even provide an autologous source of cells for future cardiac regenerative therapy [80] . However, heart repair by CM replacement appeared to be challenging and many hurdles need to be taken. These promises and challenges for hPSC-derived cellular therapies for the treatment of heart failures have been reviewed elsewhere [78, 79, 81] . One crucial aspect that we would like to emphasize here is the composition of the transplanted cell population. Which cell type(s) or tissue constructs would be most ideal regarding cell survival, tissue repair, engraftment, and functional coupling? For the delivery of organized cardiac tissue we would require scalable cultures of different cell types, such as endothelial cells, smooth muscle cells, cardiac fibroblasts, and CMs [82] . Another important aspect is the immature phenotype of hPSC-CMs. It is expected that a higher degree of maturation of transplanted CMs and thus a higher resemblance to the native myocardium would pose a less arrhythmogenic risk [83] . For cellular therapy, these major basic research challenges are important to be overcome.
Fluorescent Reporters to Track Cells After Transplantation
In cellular transplantation studies, it is crucial to monitor cell delivery, homing, survival, proliferation, and migration of transplanted cells [84] . Another important aspect is electrical coupling of transplanted cells with host myocardium at single-cell level. Impaired communication between transplanted and host CMs may lead to electrophysiological disturbances and consequently cardiac arrhythmias. In order to study both homing and electrical coupling, the use of a dual reporter, combining bioluminescence imaging and a fluorescent reporter under the control of a cardiac promoter, has been suggested [85] . However, most studies have used a single reporter line expressing either GFP or LacZ in hPSC-derived cells [80, 83, 86, 87] . Alternatively, direct cell labeling with fluorescent probes prior to transplantation, or local or systemic injections using noninvasive radionuclide imaging, magnetic labeling, or optical mapping through bioluminescence imaging are other options [85, 88] . Limitations for cell tracking that are important to consider are the half-life of the tracking label, dilution effects during cellular division and the take-up of the label by other cells after donor cell death. More details on the advantages and disadvantages of different cell tracking techniques are reviewed elsewhere [88] .
Functional Integration
Functional integration of donor cells into host myocardium can be measured by the use of fluorescent calcium dyes, such as small molecule fluo-4 [86] . Calcium is a vital component of cardiac excitation-contraction coupling. A wide range of small molecule calcium dyes is available, with different excitation/ emission spectra and affinities for calcium. When choosing a calcium dye, the affinity for calcium should be taken into account, as low-affinity calcium dyes will provide more accurate measurements of calcium dynamics (reviewed elsewhere) [89] . Moreover, high affinity dyes may interfere with the physiological calcium handling, affecting function of transplanted cells, and thereby not completely reflecting the final engraftment conditions. Another option is the use of genetically encoded calcium indicator proteins, which allows cell-specific calcium mapping over a long time period [90, 91] . This approach was recently followed in two studies where hESCCMs were transplanted in infarcted non-human primate hearts or guinea-pigs [83, 92] . Fluorescent calcium indicator GCaMP3 was incorporated in hESCs at the AAVS1, a region of the genome that is considered to be transcriptionally constitutive active, using ZFN-based genome editing. Here, they demonstrated electrical coupling between donor CMs and host myocardium. However, no significant increase in ejection fraction was found and hearts suffered from ventricular arrhythmias. The main advantages and drawbacks of the different fluorescent calcium-indicators described in this section are reviewed elsewhere [89] .
CM Proliferation
For a long period of time, the field of cardiac regeneration has been focussing on exogenous cell delivery and endogenous activation of cardiac cells to repair the damaged heart after infarction [78, 79] . Many studies have indicated that long-term beneficial improvement of cardiac function is an immense challenge.
Although several studies indicated a low proliferation rate of adult CMs [93, 94] , it is clear that mammalian adult CMs have lost the capacity to regenerate the heart after damage, as opposed to fish, amphibians, and fetal or neonatal mammalian CMs [95, 96] , therefore it is of importance to develop strategies that may lead to proliferation of cardiac progenitors (followed by differentiation to cardiovascular cells) and/or CMs. Analysis of cell division could be performed through the use of live mitosis markers, such as scaffolding protein anillin, which is a component of the contractile ring that localizes to specific subcellular compartments during mitosis and cytokinesis. Hesse et al. fused anillin to fluorescent protein eGFP, to visualize high spatiotemporal resolution of mitotic phase, and proved a lack of CM division after MI in mouse hearts [97] . Similarly, a fluorescent anillin reporter would be very valuable for studying real-time CM cell division in vitro (Fig. 3) . In addition, the fluorescence ubiquitination cell cycle indicator (FUCCI) is another system that enables live-imaging of cell division, based on a two-color (red and green) fluorescent proteins fused to cell cycle regulators ct1 and geminin, which are differentially expressed and ubiquitinated dependent on the cell-cycle stage. This leads to a dynamic color change when cells are progressing from the G1 to S phase of the cell cycle. In contrast to an anillin reporter, the FUCCI system is not suitable for demonstrating cytokinesis [98] .
THE PROMISES AND CHALLENGES OF HPSC-DERIVED CMS FOR DISEASE MODELING, AND DRUG DISCOVERY AND TOXICITY SCREENINGS
Besides the opportunity to use human stem cell-derived cardiac cells for cell-based therapies, the utility of hPSC-CMs for disease modeling, drug discovery, and toxicity screenings has been reported in a growing number of studies, allowing researchers to study patient and/or disease-specific drug responses. hPSC-CMs are a promising alternative for animal models, as they recapitulate native human CMs, indicated by expression of cardiac-specific genes and proteins, morphology, and function. Furthermore, they beat spontaneously, they possess calcium transients, and they generate action potentials that are specific for atrial, ventricular, and nodal cells [99] . However, the use of hPSC-CMs as a platform for drug discovery needs further optimization and validation and thus requires the development of tools to faithfully recapitulate cardiac physiology and function at high throughput level [100, 101] . One of the major significant challenges that scientists are facing is the mixed population of cardiac cells that are obtained from directed differentiation protocols [100, [102] [103] [104] . Therefore, it will be important to generate specific differentiation protocols in order to obtain sufficient numbers of disease-relevant subtypes of cells, which is described in detail in a previous section. Moreover, for development of advanced three-dimensional (3D) cardiac cultures with the purpose to increase the predictability of screening assays by mimicking the heart more accurately, it is important to understand the cardiac microenvironment, including cellular and noncellular compositions and cell-cell interactions [100] .
CM Electrophysiology: Voltage and Calcium Dyes
Currently published hPSC-CM disease models, including channelopathies, cardiomyopathies, and metabolic cardiac disorders, show affected (drug-induced) action and field potentials, calcium signaling, disorganized sarcomeric structures, and metabolic abnormalities such as irregular lipid or glycogen levels [105] [106] [107] . Intracellular electrophysiological recordings of singlecell hPSC-CMs by patch-clamp analysis provide detailed information about their action potential and the contribution of the ion channel currents. This has gained interest, since recent development of automated medium to high-throughput wholecell patch-clamp chip recordings [108] . An alternative approach for this labor-intensive technology is extracellular noninvasive recordings using microelectrode arrays, which is appropriate for long-term electrophysiological analysis, and is available for high-throughput screening. This will allow analysis of CM depolarization and repolarization from multicellular field potential recordings. In addition, the use of voltage-sensitive dyes represents a technology to monitor real-time electrophysiological activity at high temporal and spatial resolution [109] . These fluorescent reporters reside within the cell membrane and are able to monitor membrane potential, based on fluctuating fluorescent intensities. As these measurements can be performed at high throughput level, voltage-sensitive dyes-based assays are of high interest for drug screening in conditions that affect electrophysiological properties, such as channelopathies or drug-induced cardiotoxicity (see below). In addition, calcium handling is another important functional parameter of CM electrophysiology, for which fluorescent dyes and reporters are available. Calcium signaling in CMs is crucial for excitationcontraction coupling. During the action potential, there is a calcium influx into the cell through activation of L-type voltagegated Ca 21 channels. This results in calcium-induced calcium release from intracellular stores of the sarcoplasmic reticulum leading to contraction. Uptake of calcium from the sarcoplasm to the sarcoplasmic reticulum (in addition to other mechanisms that lead to reduced sarcoplasmic calcium levels) ends the contraction. Fluorescent calcium dyes, also described in a section above, include small molecules such as Fluo-4, Fluo-3, or Fura-2, or the more technical challenging Fura-4F, which has the advantage of a lower affinity for calcium binding, but requires switching between emission filters when calcium concentrations change [110] . Using small molecule calcium dyes, several studies have reported affected calcium handling in hPSC-CM disease models [107] . In the majority of disease modeling studies, single parameters are measured in a sequential manner. However, in order to thoroughly understand the deeper mechanisms behind the onset of disease and its phenotype outcome, it will be of interest to measure different crucial parameters simultaneously. The combination of fluorescent reporter/dyes with nonoverlapping spectra, and technological advances in LED illumination and optical filters, will make this feasible for future applications. 
Cardiac Toxicity
Drug-induced cardiotoxicity of both cardiac and noncardiac drugs is a major problem in the process of drug development and may lead to unexpected life-threatening situations [111] . For the identification of cardiotoxic effects of drugs, it is important to understand the underlying mechanisms [112] . Since current animal models and cell lines lack sufficient predictability, hPSC-CMs may represent a valuable human-based in vitro model for preclinical cardiotoxicity screenings. CM functional readouts may include calcium and voltage levels, sarcomere contraction forces and organization, ion channel functioning, CM apoptosis, mitochondrial damage, or other putative affected signaling pathways. Cellular mechanisms that have been associated with cardiotoxicity include genotoxicity, oxidative stress, apoptosis, and lipid peroxidization [113, 114] . Automated microscopy platforms in combination with fluorescent reporters/dyes enable quantification of a variety of cardiotoxic effects, such as nuclear fragmentation or caspase 3 activity to detect apoptosis, mitochondrial membrane potentials [115] [116] [117] , biochemical kinase assays based on FRET technology or specific signaling pathway analysis based on reporter assays fluorescent probes to measure cellular oxidative stress [118, 119] , or fluorescent probes to measure superoxide, produced by mitochondria under ischemic/oxidative stress conditions [120, 121] .
Companies from whom such assays are available include Toxys, Life Technologies (Cellular Pathway Analysis Assays or CellROX), or Cyprotex. In recent years, the availability of disease-specific hPSC-CMs is growing, which allows new opportunities in the field of drug development and discovery. The demand for human-based standardized and validated cardiotoxicity assays is high and the development of reliable and sensitive pathwayspecific-fluorescent reporter lines in well-characterized hPSCs in the combination with high content screening analysis methods will be promising for medium-or high-throughput screenings of cardiotoxic side effects in the field of drug discovery [115, 122] .
Optogenetics
A rapidly emerging field in biotechnology is optogenetics, which allows spatiotemporal activation of signaling cascades using green algae-derived light-sensitive cation channels, the so-called channelrhodopsins (ChR) [123] . Following activation with blue light these ChR allow the inward transfer of ions, leading to depolarization and local induction and propagation of action potentials in CMs [124, 125] . This optogenetic approach can be followed to control electrical stimulation of heart muscle and to study subsequent cellular physiological responses under healthy and diseased conditions [123, 125, 126] . Moreover, by generating hPSC-derived channelrhodopsin-expressing nodal CMs the realization of a light-activated bio-pacemaker may be feasible in the future. In addition, a recent innovative approach has been developed based on G-protein coupled receptors (GPCRs) containing motifs enabling light-induced spatiotemporal activation of GPCR-dependent pathways [127] [128] [129] . This will lead to a more in-depth understanding of specific intracellular signaling pathways in development, differentiation, and disease, and allows the identification of GPCRs and their downstream intracellular signaling cascades as therapeutic drugs target(s). Attributable to its ability to precisely control specific signaling pathways, optogenetics is a very promising technology for development of new assays in the field of drug development and toxicity, especially in combination with future 3D-disease modeling.
CM MATURATION AND SARCOMERIC STRUCTURES
One of the biggest challenges for the use of hPSC-CMs for preclinical drug screening is to increase the degree of maturity of hPSC-CMs [130] . Although morphological and functional aspects of hPSC-CMs resemble those of fetal CMs, they still show a lack of maturity; hPSC-CMs are smaller in size, their sarcomeres, the smallest contractile units of striated muscles, have shown to be less organized when compared to adult CMs, they exhibit a lower contractile force and immature electrophysiological properties, and their metabolism is based on glycolysis, whereas adult CMs mainly use fatty acids as metabolic substrate [130, 131] . The lack of a mature phenotype may affect mechanistic and functional aspects of hPSC-CMs and consequently may result in a different druginduced or disease-specific response. A higher degree of maturity is therefore most likely important for disease modeling and drug screening [100, 132] . Strategies to increase maturation in order to mimic human adult CMs are followed with much interest. In addition, sarcomeric organization can be affected in hPSC-CM disease models and drug-induced cardiotoxicity [107] . It will therefore be of interest to study the organization of sarcomeric structures in hPSC-CMs with respect to the degree of maturation, and disease-and/or toxicity-induced sarcomeric disorganization (Fig. 4) . In order to allow live-imaging for detailed analysis, a reporter line harboring a fluorescent protein fused to sarcomeric proteins may be a valuable additional tool, provided that the fusion protein will not affect CM function [133] .
CONCLUSIONS AND FUTURE OUTLOOK
Here, we reviewed the role of fluorescent hPSC reporter lines to our growing insights into cardiac differentiation, and their applications in the fields of cardiac regeneration, drug discovery, and toxicity screening. Fluorescent hPSC reporter lines have shown their advantages in the development and optimization of efficient cardiac differentiation protocols and will also be of high interest for deciphering the molecular signatures and mechanisms of differentiation of cardiac subtypes (Table 2) , using technologies such as epigenetics (histone modifications, chromatin dynamics), transcriptomics, proteomics, and metabolomics [134] . The use of dual-or multifluorescent reporter lines will have an additional advantage. In this manner, sequential lineage decisions can be visualized in realtime, which can be combined with in-depth molecular and functional single-cell analysis [135] . A deeper understanding of the processes that determine maintenance and self-renewal of cardiac progenitors and thereby may provide an unlimited source of functional cardiac cells, will constitute an important contribution for the advancement of the fields of regenerative medicine, drug discovery, and safety pharmacology. The identification of cell surface markers on specific cardiac cell subtypes allows enrichment of CMs through cell sorting, which will be advantageous for the development of robust and validated assays for CM biology and/or function and for cellbased transplantation studies. In addition, improved knowledge on expansion and differentiation of cardiac progenitors may have far-reaching implications for the discovery of new therapies with a focus on activation of endogenous cardiac progenitors for the treatment of heart failure. In the context of heart repair it will also be of importance to visualize other biological processes such as cell death (necrosis and apoptosis) and the formation of celltypes following differentiation within their own lineage or as a Abbreviations: CM, cardiomyocyte; CPC, Cardiac Progenitor Cell.
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result from switching cellular fate (e.g., via directed reprogramming). In this regard, subcellular labeling of cells using fluorescent proteins fused to specific localization signals, which target different organelles or compartments of the cell (e.g., membrane, cytosol, or nucleus), offer an additional advantage for identification and tracking of transplanted cells in complex multicolor labeling experiments. We have discussed the advantages of fluorescent reporters in cell-based transplantation studies, indicated by the possibility to visualize engrafted cells (i.e., homing and survival) and to study functional integration and maturation into the host myocardium (Table 3) . Combination of these fluorescent reporter lines with other advanced reporter lines, such as those based on optogenetics, enables studying specific signaling pathways in a temporal spatial manner. In this context, the use of the light-sensitive cation channels, channelrhodopsins (ChR), derived from green algae, allow the inward transfer of ions following activation with blue light, leading to depolarization of CM and local induction of action potentials that are propagated to electrically coupled neighboring cells [124, 125] . This optogenetic approach can be followed to control electrical stimulation of heart muscle and to study subsequent cellular physiological responses under healthy and diseased conditions [123, 125, 126] . Moreover, by generating hPSC-derived channelrhodopsin-expressing nodal CMs the realization of a light-activated bio-pacemaker is one step closer. Besides the in vivo applications, these reporter-based strategies have an important role for the further development and optimization of human in vitro assays for drug discovery, safety pharmacology, and disease modeling.
Finally, use of reporter-based assays and cardiac celltypes facilitates the development of 3D tissues or organ-like structures for tissue engineering and generation of highly advanced models that are more closely resembling the human heart using a multidisciplinary approach. It will be intriguing to see how, among others, the emerging and widely discussed 3D bioprinting technology may contribute to achieve this goal. In addition to CM subtypes, additional cardiac cell-types, including vascular cells and fibroblasts, and the right composition of extracellular matrix components need to be included in order to generate these structures. Clearly, many hurdles need to be overcome, but increased interest of academia and industry in the use of human stem cell-based assays (Table 4) will stimulate this field and likely increases the pace of its development, which will be a big step forward in improving efficient, costeffective, and safe drug development and effective therapies for the treatment of cardiac diseases.
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